George W. Ebright

85 year

Health Technology

Profile

George W.
Ebright has been a Director of Arrow International Inc since October 1993.
Director of Cytogen Corporation, a biopharmaceutical company engaged in the development of diagnostic and therapeutic substances for human health care applications ("Cytogen"), from February 1989 until May 1995.
Chairman of the Board of Cytogen from February 1990 until January 1995 and President from February 1989 to August 1991.
Prior thereto, President and Chief Operating Officer and a director of SmithKline Beckman Corporation, a health care and life services company engaged in the marketing of a broad line of prescription and proprietary products for human and animal health care, as well as diagnostic and analytical products and services.
From 1963 through 1987, held several senior management positions with SmithKline & French Laboratories and two of its divisions.
Director of NABI, Inc., a biopharmaceutical company which develops products for the prevention and treatment of infectious diseases, and The West Company, a supplier of specialized packaging systems to the health care and consumer products industries.

Former positions of George W. Ebright

Companies	Position	End
Nabi Biopharmaceuticals Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD.	Director/Board Member	2006-03-26

See the detail of George W. Ebright's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies